Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03943537
PHASE2

Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

Sponsor: Mclean Hospital

View on ClinicalTrials.gov

Summary

This clinical trial is a single center, single dose study of the acute effects of intranasal insulin on energy metabolism and cognitive function in patients with schizophrenia, schizoaffective and bipolar disorders, compared and healthy controls.

Key Details

Gender

All

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

87

Start Date

2019-10-01

Completion Date

2024-02-23

Last Updated

2026-09-03

Healthy Volunteers

Yes

Interventions

DRUG

Intranasal Insulin

40 units Novolin R administered intranasally using ViaNase device.

Locations (1)

McLean Hospital

Belmont, Massachusetts, United States